LGR5 promotes the proliferation and tumor formation of cervical cancer cells through the Wnt/β-catenin signaling pathway

Oncotarget

Volumn 5, Issue 19, 2014, Pages 9092-9105

  Chen, Qing ^a   Cao, Hao Zhe ^a   Zheng, Peng Sheng ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cell cycle; Cervical cancer; LGR5; Proliferation; Wnt catenin signaling

Indexed keywords

BETA CATENIN; CYCLIN D1; DICKKOPF 1 PROTEIN; G PROTEIN COUPLED RECEPTOR; LEUCINE RICH REPEAT CONTAINING G PROTEIN COUPLED RECEPTOR 5; MYC PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CCND1 PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; LGR5 PROTEIN, HUMAN; MYC PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; FEMALE; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; CANCER TRANSPLANTATION; CELL CYCLE; CELL SURVIVAL; CELL TRANSFORMATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; UTERINE CERVIX; UTERINE CERVIX TUMOR; WNT SIGNALING PATHWAY; XENOGRAFT;

ANIMALS; BETA CATENIN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CERVIX UTERI; CYCLIN D1; FEMALE; HELA CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTORS, G-PROTEIN-COUPLED; TRANSPLANTATION, HETEROLOGOUS; UTERINE CERVICAL NEOPLASMS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84910076995     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.2377     Document Type: Article

References (45)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D. Global cancer statistics. CA: a cancer journal for clinicians. 2011; 61(2):69-90.
2. Brebi M, Ili G, López M, García M, Melo A, Montenegro H, Leal R, Guzmán G and Roa S. Detection and genotyping of human papillomavirus in biopsies of uterine cervical adenocarcinoma. Revista Médica de Chile. 2009; 137(3):377-382.
3. Saavedra KP, Brebi PM and Roa JCS. Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix. Clinical Epigenetics. 2012; 4(1):1-7.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999; 189(1):12-19.
5. Garland S, Hernandex-Avila M and Wheeler C. Cervical Cancer and HPV Vaccination. N Eng J Med. 2007; 356:1915-1927.
6. Ji J and Zheng P-S. Expression of Sox2 in human cervical carcinogenesis. Human pathology. 2010; 41(10):1438-1447.
7. Gu T-T, Liu S-Y and Zheng P-S. Cytoplasmic NANOG-Positive Stromal Cells Promote Human Cervical Cancer Progression. The American journal of pathology. 2012; 181(2):652-661.
8. Yang WT and Zheng PS. Krüppel-like factor 4 functions as a tumor suppressor in cervical carcinoma. Cancer. 2012; 118(15):3691-3702.
9. Wang Y, Cai N, Wu X, Cao H, Xie L and Zheng P. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway. Cell death & disease. 2013; 4(8):e760.
10. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M and Hsueh AJ. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Molecular endocrinology. 2000; 14(8):1257-1271.
11. Hsu SY, Liang SG and Hsueh aJ. Characterization of two LGR genes homologous to gonadotropin and thyrotropin receptors with extracellular leucine-rich repeats and a G protein-coupled, seven-transmembrane region. Molecular endocrinology (Baltimore, Md). 1998; 12:1830-1845.
12. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449:1003-1007.
13. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H and Toftgård R. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nature genetics. 2008; 40:1291-1299.
14. Barker N and Clevers H. Leucine-rich repeat-containing G-protein-coupled receptors as markers of adult stem cells. Gastroenterology. 2010; 138(5):1681-1696.
15. Al-Kharusi MR, Smartt HJ, Greenhough A, Collard TJ, Emery ED, Williams AC and Paraskeva C. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs. Carcinogenesis. 2013; 34(5):1150-1157.
16. Colon H, Tumors OP, Mcclanahan T, Koseoglu S, Smith K, Grein J, Gustafson E, Black S, Kirschmeier P and Samatar AA. Identification of Overexpression of Orphan G Protein-Coupled Receptor GPR49 in Human Colon and Ovarian Primary Tumors. Cancer biology & therapy. 2006; 5(4):419-426.
17. Yamamoto Y, Sakamoto M, Fujii G, Tsuiji H, Kenetaka K, Asaka M and Hirohashi S. Overexpression of orphan G-protein-coupled receptor, Gpr49, in human hepatocellular carcinomas with beta-catenin mutations. Hepatology (Baltimore, Md). 2003; 37:528-533.
18. Tanese K, Fukuma M, Yamada T, Mori T, Yoshikawa T, Watanabe W, Ishiko A, Amagai M, Nishikawa T and Sakamoto M. G-protein-coupled receptor GPR49 is up-regulated in basal cell carcinoma and promotes cell proliferation and tumor formation. The American journal of pathology. 2008; 173:835-843.
19. Becker L, Huang Q and Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarcinoma. Diseases of the esophagus: official journal of the International Society for Diseases of the Esophagus / ISDE. 2010; 23(2):168-174.
20. Rot S, Taubert H, Bache M, Greither T, Würl P, Eckert AW, Schubert J, Vordermark D and Kappler M. A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients. BMC cancer. 2011; 11:429.
21. Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona X, da Silva-Diz V, Muñoz P, Clevers H, Sancho E, Mangues R and Batlle E. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell stem cell. 2011; 8:511-524.
22. Kemper K, Prasetyanti PR, De Lau W, Rodermond H, Clevers H and Medema JP. Monoclonal antibodies against Lgr5 identify human colorectal cancer stem cells. Stem cells (Dayton, Ohio). 2012; 30(11):2378-2386.
23. Wend P, Holland JD, Ziebold U and Birchmeier W. Wnt signaling in stem and cancer stem cells. Seminars in cell & developmental biology. 2010; 21:855-863.
24. Schlange T, Matsuda Y, Lienhard S, Huber A and Hynes NE. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation. Breast Cancer Res. 2007; 9(5):R63.
25. Carmon KS, Gong X, Lin Q, Thomas A and Liu Q. R-spondins function as ligands of the orphan receptors LGR4 and LGR5 to regulate Wnt/beta-catenin signaling. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(28):11452-11457.
26. Carmon KS, Lin Q, Gong X, Thomas A and Liu Q. LGR5 interacts and cointernalizes with Wnt receptors to modulate Wnt/beta-catenin signaling. Molecular and cellular biology. 2012; 32(11):2054-2064.
27. Wu XS, Xi HQ and Chen L. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival. World journal of surgical oncology. 2012; 10:244.
28. Hao XP, Willis JE, Pretlow TG, Rao JS, MacLennan GT, Talbot IC and Pretlow TP. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions. Cancer research. 2000; 60(1):18-21.
29. Zhang Y, Li B, Ji ZZ and Zheng PS. Notch1 regulates the growth of human colon cancers. Cancer. 2010; 116(22):5207-5218.
30. Ootani A, Li X, Sangiorgi E, Ho QT, Ueno H, Toda S, Sugihara H, Fujimoto K, Weissman IL and Capecchi MR. Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche. Nature medicine. 2009; 15(6):701-706.
31. de Lau W, Barker N, Low TY, Koo B-K, Li VSW, Teunissen H, Kujala P, Haegebarth A, Peters PJ, van de Wetering M, Stange DE, van Es JE, Guardavaccaro D, Schasfoort RBM, Mohri Y, Nishimori K, et al. Lgr5 homologues associate with Wnt receptors and mediate R-spondin signalling. Nature. 2011; 476:293-297.
32. Kim K-A, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E and Emtage P. Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science. 2005; 309(5738):1256-1259.
33. Scannell CA, Pedersen EA, Mosher JT, Krook MA, Nicholls LA, Wilky BA, Loeb DM and Lawlor ER. LGR5 is Expressed by Ewing Sarcoma and Potentiates Wnt/beta-Catenin Signaling. Frontiers in oncology. 2013; 3:81.
34. Binnerts ME, Kim K-A, Bright JM, Patel SM, Tran K, Zhou M, Leung JM, Liu Y, Lomas WE and Dixon M. R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proceedings of the National Academy of Sciences. 2007; 104(37):14700-14705.
35. Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ and Clevers H. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007; 449(7165):1003-1007.
36. Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H and Toftgard R. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nature genetics. 2008; 40(11):1291-1299.
37. Fan X-S, Wu H-Y, Yu H-P, Zhou Q, Zhang Y-F and Huang Q. Expression of Lgr5 in human colorectal carcinogenesis and its potential correlation with beta-catenin. International journal of colorectal disease. 2010; 25:583-590.
38. von Rahden BHa, Kircher S, Lazariotou M, Reiber C, Stuermer L, Otto C, Germer CT and Grimm M. LgR5 expression and cancer stem cell hypothesis: clue to define the true origin of esophageal adenocarcinomas with and without Barrett's esophagus? Journal of experimental & clinical cancer research: CR. 2011; 30:23.
39. Yamanoi K, Fukuma M, Uchida H, Kushima R, Yamazaki K, Katai H, Kanai Y and Sakamoto M. Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in gastric cancer. Pathology international. 2013; 63(1):13-19.
40. Wang D, Zhou J, Fan C, Jiao F, Liu B, Sun P, Miao J and Zhang Q. Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo. Oncology reports. 2014; 31(1):41-49.
41. Walker F, Zhang H-H, Odorizzi A and Burgess AW. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines. PloS one. 2011; 6:e22733.
42. Glinka A, Dolde C, Kirsch N, Huang Y-L, Kazanskaya O, Ingelfinger D, Boutros M, Cruciat C-M and Niehrs C. LGR4 and LGR5 are R-spondin receptors mediating Wnt/β-catenin and Wnt/PCP signalling. EMBO reports. 2011; 12(10):1055-1061.
43. Antony W. Burgess a, Maree C. Faux a, Meredith J. Layton b, Robert G. Ramsay c, d. Wnt signaling and colon tumorigenesis-A view from the periphery. Exprerental cell research. 2011; 317: 2 7 4 8-2 7 5 8.
44. Qu Q, Sun G, Li W, Yang S, Ye P, Zhao C, Ruth TY, Gage FH, Evans RM and Shi Y. Orphan nuclear receptor TLX activates Wnt/β-catenin signalling to stimulate neural stem cell proliferation and self-renewal. Nature cell biology. 2010; 12(1):31-40.
45. Dravid G, Ye Z, Hammond H, Chen G, Pyle A, Donovan P, Yu X and Cheng L. Defining the Role of Wnt/β-Catenin Signaling in the Survival, Proliferation, and Self-Renewal of Human Embryonic Stem Cells. Stem cells (Dayton, Ohio). 2005; 23(10):1489-1501.